C. Ward

ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs)

Rohini Sharma, H. Izadi, F. Wernig, 2022, BMC cancer.

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

N. Habib, Rohini Sharma, V. Yip, 2021, BMC Cancer.

The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development

M. Kudo, T. Arizumi, D. Bettinger, 2017, Alimentary pharmacology & therapeutics.

Hepatology Basic Science

D. Hume, M. Odenthal, R. Büttner, 2018, Journal of Gastroenterology and Hepatology.

PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma.

Rohini Sharma, A. Cortellini, D. Pinato, 2023, Future oncology.

Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.

M. Odenthal, Shahid A. Khan, R. Büttner, 2019, European journal of cancer.

Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease

L. Bolondi, H. Reeves, Rohini Sharma, 2022, Liver Cancer.

A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL

Ching Ngar Wong, A. Akarca, T. Marafioti, 2019, Annals of Oncology.